CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-16 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −45,000 | $28.00 | $1.3M | 25,204 |
| 2018-01-16 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion | +1,110 | $12.57 | $14K | 26,314 |
| 2018-01-16 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −1,110 | $28.24 | $31K | 25,204 |
| 2018-01-16 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion | +19,890 | $12.57 | $250K | 45,094 |
| 2018-01-16 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −19,890 | $28.10 | $559K | 25,204 |
| 2018-01-16 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,110 | 36,663 | ||
| 2018-01-16 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −19,890 | 5,237 | ||
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −30,000 | $20.55 | $617K | 70,204 |
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion | +8,000 | $12.57 | $101K | 78,204 |
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −8,000 | $25.75 | $206K | 70,204 |
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −6,490 | 37,773 | ||
| 2018-01-02 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,510 | 25,157 | ||
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion | +6,230 | $14.43 | $90K | 121,434 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −6,230 | $21.75 | $136K | 115,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion | +9,070 | $12.57 | $114K | 124,274 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −1,070 | $21.75 | $23K | 123,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −8,000 | $23.76 | $190K | 115,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Sale | −15,000 | $22.68 | $340K | 100,204 |
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −6,230 | 58,070 | ||
| 2017-12-29 | Dylan-Hyde Tyler Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −9,070 | 44,263 |
Page 1 of 2 · 39 trades